7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
      
    		                             
      cash flows from operating activities:
    		                             
      net income
    		-298,200,000 -4,700,000 -202,100,000 -135,600,000 -20,700,000 -32,800,000 -163,500,000 -182,000,000 12,300,000 8,600,000 -235,500,000 -287,700,000 -226,900,000 -121,600,000 -337,400,000 -134,400,000 -224,200,000 -344,000,000 -567,200,000  -905,800,000 -561,200,000 -2,176,300,000       
      adjustments to reconcile net income to net cash from operating activities:
    		                             
      depreciation and amortization
    		79,400,000 77,800,000 76,100,000 78,300,000 80,800,000 78,800,000 81,600,000 85,900,000 88,700,000 96,800,000 93,600,000 103,000,000 96,900,000 97,400,000 98,700,000 101,500,000 103,700,000 105,700,000 114,100,000 132,600,000 123,500,000 119,700,000 122,500,000 112,900,000 112,100,000 112,000,000 113,000,000 -398,399,462.2 130,200,000 
      gain on extinguishment of debt
    		    50,800,000 -85,300,000 -5,800,000                       
      gain on derivatives
    		                             
      deferred income taxes
    		400,000 0 900,000 400,000 400,000 200,000 500,000 -100,000 400,000 -200,000 600,000 600,000 800,000 400,000 -100,000 4,000,000 700,000 -6,100,000 -6,200,000 -1,200,000 -200,000 -5,800,000 71,200,000 -40,700,000 -1,900,000 4,800,000 4,100,000 3,499,993.6 -1,500,000 
      unrealized gain on investments in hycroft
    		-9,300,000 300,000 -2,800,000      700,000     47,800,000 -63,900,000               
      impairment of equity security
    		                             
      amortization of net discount (premium) on corporate borrowings to interest expense
    		2,800,000 4,400,000 4,200,000          -16,500,000 -16,500,000 -15,500,000 -14,400,000    -17,800,000          
      amortization of deferred financing costs to interest expense
    		3,400,000 2,000,000 1,900,000 1,600,000 2,200,000 2,000,000 2,500,000 2,500,000 2,400,000 2,400,000 2,300,000 2,600,000 3,200,000 3,300,000 3,500,000 3,800,000 4,000,000 3,400,000 12,100,000 2,600,000          
      pik interest expense
    		11,600,000 8,500,000 8,600,000             0 9,100,000 54,400,000 52,700,000 43,600,000          
      non-cash portion of stock-based compensation
    		6,000,000 6,000,000 5,700,000 6,900,000 6,300,000 4,500,000 4,300,000 1,600,000 7,200,000 7,800,000 25,900,000 200,000 -3,600,000 19,400,000 6,500,000 24,300,000 5,000,000 8,400,000 5,400,000 15,900,000 3,100,000 3,700,000 2,700,000 -7,100,000 2,100,000 5,400,000 4,000,000 -10,899,985.1 4,100,000 
      equity in earnings of non-consolidated entities, net of distributions
    		600,000                             
      lease incentives
    		18,600,000 4,700,000 4,200,000                           
      deferred rent
    		-29,600,000 -26,200,000 -26,800,000 -24,000,000 -48,300,000 -17,400,000 -16,400,000 -26,400,000 -27,300,000 -31,800,000 -38,600,000 -39,900,000 -39,500,000 -42,000,000 -48,700,000 -49,200,000 -54,600,000 -8,100,000 -21,800,000 11,500,000 17,700,000 -7,500,000 -18,300,000 -17,000,000 -15,900,000 -11,300,000 -18,100,000 81,299,898.4 -16,600,000 
      net periodic benefit cost
    		300,000 300,000 300,000 300,000 400,000 400,000 700,000 100,000 500,000       -400,000 -100,000 -200,000 -200,000 1,000,000 200,000 300,000 300,000 400,000 700,000 500,000 100,000 -499,998.9 400,000 
      change in assets and liabilities:
    		                             
      receivables
    		18,900,000 -24,000,000 73,900,000 -61,200,000 57,400,000 -17,600,000 58,800,000 -67,900,000 -11,100,000 -33,600,000 67,000,000 -57,100,000 14,700,000 -17,200,000 63,600,000 -40,900,000 -48,100,000 9,000,000 -2,700,000 -6,000,000 -12,000,000 47,900,000 129,400,000 -93,100,000 61,800,000 -36,300,000 68,300,000 -117,100,000.2 34,800,000 
      other assets
    		9,300,000 4,200,000 -14,400,000 2,100,000 -100,000 11,000,000 -23,700,000 6,200,000 16,900,000 -1,300,000 -28,500,000 18,100,000 10,500,000 4,300,000 -30,600,000 28,300,000 -23,100,000 2,000,000 -13,000,000 9,500,000 17,700,000 20,400,000 29,200,000 34,100,000 -21,800,000 4,100,000 14,500,000 -8,900,000.4 15,600,000 
      accounts payable
    		-32,400,000 46,900,000 -134,400,000 142,700,000 -74,000,000 39,500,000 -48,100,000 69,800,000 -45,000,000 39,700,000 -65,200,000 98,500,000 -80,500,000 22,000,000 -80,400,000 95,000,000 36,700,000 -56,000,000 -11,900,000 -55,200,000 -66,200,000 114,800,000 -169,800,000 206,000,000 -65,500,000 41,000,000 -76,700,000 190,999,914.4 -149,000,000 
      accrued expenses and other liabilities
    		1,800,000 59,100,000 -109,500,000 77,200,000 -25,300,000 -3,200,000 -62,500,000 3,200,000 46,600,000 -55,500,000 -21,000,000 53,900,000 -10,400,000 -49,900,000 -32,800,000 -24,500,000 72,000,000 20,400,000 96,400,000 85,300,000 116,500,000 6,400,000 -105,700,000 54,800,000 8,600,000 -16,000,000 -48,000,000 13,500,068.5 65,500,000 
      other
    		6,100,000 -24,600,000 -10,800,000 17,400,000 -21,100,000 -5,500,000 3,000,000 -21,800,000 15,700,000 -9,500,000 -12,000,000 -41,300,000 400,000 6,700,000 8,200,000 -21,600,000 1,400,000 2,200,000 -11,900,000 -5,600,000 19,300,000 6,000,000 23,500,000 -4,300,000 -1,000,000 -7,700,000 5,500,000 4,599,993.9 -1,000,000 
      net cash from operating activities
    		-14,900,000 138,400,000 -370,000,000 203,600,000 -31,500,000 -34,600,000 -188,300,000 -77,800,000 65,900,000 -13,400,000 -189,900,000 -33,300,000 -223,600,000 -76,600,000 -295,000,000 46,500,000 -113,900,000 -233,800,000 -312,900,000 -357,900,000 -355,700,000 -231,900,000 -184,000,000 368,800,000 56,600,000 152,200,000 1,400,000 -298,799,476.8 1,700,000 
      cash flows from investing activities:
    		                             
      capital expenditures
    		-66,200,000 -49,500,000 -47,000,000 -89,700,000 -60,700,000 -44,600,000 -50,500,000 -72,100,000 -57,500,000 -48,600,000 -47,400,000 -72,300,000 -54,500,000 -40,400,000 -34,800,000 -38,500,000 -24,100,000 -17,900,000 -11,900,000 -17,800,000 -29,300,000 -35,000,000 -91,700,000 -169,900,000 -118,300,000 -115,100,000 -114,800,000 374,899,423.7 -133,800,000 
      free cash flows
    		-81,100,000 88,900,000 -417,000,000 113,900,000 -92,200,000 -79,200,000 -238,800,000 -149,900,000 8,400,000 -62,000,000 -237,300,000 -105,600,000 -278,100,000 -117,000,000 -329,800,000 8,000,000 -138,000,000 -251,700,000 -324,800,000 -375,700,000 -385,000,000 -266,900,000 -275,700,000 198,900,000 -61,700,000 37,100,000 -113,400,000 76,099,946.9 -132,100,000 
      proceeds from disposition of long-term assets
    		800,000   200,000 100,000   7,900,000 2,600,000 5,200,000 800,000 500,000 3,600,000 0 7,200,000 4,500,000 2,000,000 -3,800,000 5,200,000 17,400,000 4,900,000 300,000 3,400,000 1,800,000 100,000 4,000,000 17,300,000 -13,899,985.8 400,000 
      investments in non-consolidated entities
    		           0 0 0 -27,900,000 0 0 0 -9,300,000 0 0   -200,000 -9,400,000 0 -100,000 10,999,988.6 -300,000 
      net cash from investing activities
    		-68,300,000 -48,700,000 -46,900,000 -88,900,000 -60,500,000 -43,500,000 -50,000,000 -63,700,000 -59,000,000 -40,800,000 -16,600,000 -70,300,000 -50,800,000 -48,000,000 -54,900,000 -36,900,000 -28,800,000 13,500,000 -16,000,000 200,000 -23,300,000 -44,100,000 -87,400,000 -167,700,000 -127,100,000 -122,800,000 -98,500,000 114,299,682.8 67,200,000 
      cash flows from financing activities:
    		                             
      net proceeds from equity issuances
    		0   11,900,000 0   340,300,000                      
      proceeds from issuance of senior secured notes due 2029
    		                             
      principal payments under the second lien notes due 2026
    		                             
      principal payments under senior subordinated notes due 2025
    		0                             
      principal payments under senior subordinated notes due 2026
    		                             
      proceeds from issuance of term loan due 2029
    		   0                          
      scheduled principal payments under term loan borrowings
    		-5,100,000 -5,000,000 -5,000,000 -5,000,000                          
      principal payments under finance lease obligations
    		-1,100,000 -1,100,000 -800,000 -1,100,000 -1,100,000 -1,200,000 -1,200,000 -1,000,000 -1,500,000 -1,500,000 -1,600,000 -1,500,000 -2,500,000 -2,900,000 -2,500,000 -2,800,000 -2,300,000 -2,000,000 -1,900,000 -1,700,000 -2,200,000 0 -2,300,000       
      repurchase of senior subordinated notes due 2025
    		0 0 -1,300,000 -1,900,000                          
      repurchase of senior subordinated notes due 2026
    		   0    0 0 0 -1,700,000                   
      repurchase of second lien notes due 2026
    		   0    -40,100,000 -17,400,000 -27,600,000 -54,800,000  0                 
      principal payments under term loan due 2026
    		   0                          
      cash used to pay deferred financing costs
    		-37,500,000 0 -100,000                           
      debt extinguishment costs
    		   -1,600,000                          
      taxes paid for restricted unit withholdings
    		0 0 -4,400,000 0 0 0 -2,200,000 0 0 -1,100,000 -13,100,000 -100,000 0 0 -52,200,000     -4,100,000 0 0 -1,000,000 0 0 -200,000 -1,100,000 1,699,998.3 0 
      net cash from financing activities
    		25,200,000 -48,900,000 158,000,000 -3,700,000 -155,200,000 236,300,000 -9,000,000 294,000,000 292,900,000 -6,500,000 68,900,000 44,200,000 500,000 -59,700,000 -76,300,000 -27,900,000 -48,300,000 1,212,200,000 854,700,000 247,800,000 296,600,000 473,500,000 312,400,000 -40,000,000 -18,400,000 -20,600,000 -33,900,000 155,299,805.2 -37,400,000 
      effect of exchange rate changes on cash and cash equivalents and restricted cash
    		-200,000 6,600,000 5,800,000 -7,300,000 5,700,000 -300,000 -3,400,000    1,900,000 8,000,000 -8,200,000 -16,400,000 -5,500,000 -1,600,000 -8,400,000 5,600,000 -5,100,000 2,500,000 2,800,000 1,100,000 -6,700,000 3,800,000 -1,700,000 -2,800,000 2,200,000 3,199,994.5 -14,600,000 
      net decrease in cash and cash equivalents and restricted cash
    		-58,200,000 47,400,000 -253,100,000   157,900,000 -250,700,000                       
      cash and cash equivalents and restricted cash at beginning of period
    		0 0 680,800,000 0 0 0 911,400,000     0 0   0   321,400,000 0   275,500,000 0 0 0 324,000,000 -318,299,681.7 0 
      gain on derivative liability
    		 3,900,000 -45,100,000 -2,300,000                          
      cash and cash equivalents and restricted cash at end of period
    		 47,400,000 427,700,000 103,700,000 -241,500,000 157,900,000 660,700,000     -51,400,000 -282,100,000   -19,900,000   842,100,000 -107,400,000   309,800,000 164,900,000 -90,600,000 6,000,000 195,200,000 -344,299,676 16,900,000 
      supplemental disclosures of cash flow information:
    		                             
      cash paid during the period for:
    		                             
      interest
    		 97,400,000 92,900,000   114,600,000 77,800,000     124,500,000 75,800,000   158,100,000    55,400,000   34,600,000 100,400,000 37,900,000 108,100,000 38,100,000 -175,099,721.7 36,800,000 
      income taxes paid
    		 1,900,000 900,000   1,400,000 200,000                1,700,000    2,500,000 -9,899,980.5 1,500,000 
      schedule of non-cash activities:
    		                             
      construction payables at period end
    		 10,100,000 28,500,000   11,000,000 23,800,000     -2,300,000 7,700,000   22,400,000    -14,300,000   58,400,000 7,900,000 1,700,000 3,600,000 83,800,000 -102,299,899.2 10,300,000 
      deferred financing costs payable
    		                             
      extinguishment of second lien notes due 2026 in exchange for share issuance
    		                             
      equity in earnings from non-consolidated entities, net of distributions
    		  100,000    -2,400,000                     32,399,960  
      net proceeds (disbursements) from equity issuances
    		  169,600,000                           
      other third-party equity issuance costs payable
    		      100,000                       
      (gain) loss on extinguishment of debt
    		       -45,300,000 -10,800,000 -21,600,000 -65,100,000                   
      impairment of long-lived assets
    		                             
      unrealized loss on investments in hycroft
    		   1,300,000 1,400,000 -700,000 1,000,000                       
      amortization of net premium on corporate borrowings to interest expense
    		   2,600,000 1,100,000 -10,000,000 -11,200,000 -12,900,000 -13,500,000 -14,000,000 -15,200,000       -17,800,000 42,300,000           
      gain on disposition of saudi cinema company
    		       0 0 0 -15,500,000                   
      equity in (earnings) income from non-consolidated entities, net of distributions
    		                   5,100,000 10,700,000         
      landlord contributions
    		   5,800,000 10,400,000 11,000,000 4,600,000 7,900,000 7,700,000 1,900,000 6,400,000 3,700,000 11,000,000 4,600,000 600,000 4,300,000 6,600,000 7,400,000 3,700,000 11,700,000 7,000,000 8,800,000 16,100,000 17,500,000 24,200,000 29,600,000 35,200,000 -100,099,872.4 27,800,000 
      non-cash shareholder litigation expense
    		       0 -16,100,000 -1,200,000 116,600,000                   
      acquisition of theatre assets
    		       0    0 0   -2,400,000        0 0     
      proceeds from disposition of saudi cinema company
    		       0 0 0 30,000,000                   
      proceeds from sale of securities
    		           1,600,000 0                 
      proceeds from issuance of first lien notes due 2029
    		           0 0 0 950,000,000               
      proceeds from issuance of odeon senior secured notes due 2027
    		                             
      principal payments under first lien notes due 2025
    		           0 0 0 -500,000,000               
      principal payments under first lien notes due 2026
    		           0 0 0 -300,000,000               
      principal payments under first lien toggle notes due 2026
    		           0 0 0 -73,500,000 0              
      principal payments under odeon term loan facility
    		                             
      principal payments under senior subordinated notes due 2024
    		                             
      premium paid to extinguish first lien notes due 2025
    		           0 0 0 -34,500,000               
      premium paid to extinguish first lien notes due 2026
    		           0 0 0 -25,600,000               
      premium paid to extinguish first lien toggle notes due 2026
    		           0 0 0 -14,600,000 0              
      premium paid to extinguish odeon term loan facility
    		                             
      repurchase of senior subordinated notes due 2027
    		                             
      cash used to pay dividends
    		           0 0 0 -700,000     -2,200,000 0 0 -4,300,000 -20,700,000 -20,800,000 -20,800,000 -21,800,000 237,399,741.9 -186,000,000 
      net increase in cash and cash equivalents and restricted cash
    		   103,700,000        -51,400,000 -282,100,000   -19,900,000 -199,400,000 997,500,000 520,700,000 -107,400,000 -79,600,000 198,600,000 34,300,000 164,900,000 -90,600,000 6,000,000 -128,800,000 -25,999,994.3 16,900,000 
      investment in ncm
    		           0 -100,000       1,400,000   4,500,000  300,000 -100,000 1,400,000 6,299,993.7 0 
      extinguishment of the 2025 notes in exchange for share issuance
    		                             
      extinguishment of the 2026 notes in exchange for share issuance
    		                             
      extinguishment of second lien notes due 2026 in exchange for term loans due 2029
    		                             
      extinguishment of principal amount of the second lien notes due 2026 in exchange for term loan due 2029
    		                             
      extinguishment of principal amount of the second lien notes due 2026 in exchange for exchangeable notes due 2030
    		                             
      equity in (earnings) from non-consolidated entities, net of distributions
    		                             
      cash used to pay for deferred financing costs
    		    -44,600,000 -1,000,000 -100,000 -200,000 100,000 -400,000 -1,500,000 -6,800,000 200,000 -1,800,000 -17,700,000 0 -600,000 -300,000 -19,000,000 -200,000 -5,900,000 -9,200,000 -100,000     14,299,984.5 -12,100,000 
      other non-cash rent benefit
    		     -10,700,000 -11,700,000 -8,000,000 -8,400,000 -9,000,000 -9,600,000 -6,000,000 -6,600,000 -6,900,000 -7,100,000  -3,000,000             
      scheduled principal payments under term loan due 2026
    		     -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000           
      net (disbursements) proceeds from equity issuances
    		      -500,000                       
      gain on dispositions of baltics
    		                             
      proceeds from disposition of baltics, net of cash and transaction costs
    		               0 -1,000,000             
      proceeds from issuance of odeon term loan facility
    		                             
      proceeds from first lien toggle notes due 2026
    		               0 0 0 100,000,000           
      principal payments under second lien notes due 2026
    		                             
      repayments under revolving credit facilities
    		                         -8,200,000 -3,800,000   
      payments related to sale of noncontrolling interest
    		                0 -100,000 -300,000           
      income taxes paid (received)
    		           -300,000 -300,000                 
      convertible notes due 2026 conversion, see note 8-corporate borrowings and finance lease liabilities
    		                             
      equity in gain from non-consolidated entities, net of distributions
    		                             
      effect of exchange rate changes on cash and cash equivalents and
    		        -5,900,000                     
      equity in income from non-consolidated entities, net of distributions
    		           -200,000 1,100,000 900,000 5,800,000 -3,500,000 -700,000 2,700,000 2,800,000    11,200,000       
      net proceeds from amc preferred equity units issuance
    		         29,100,000 146,600,000 212,600,000                  
      unrealized gain on investments hycroft
    		          4,600,000                   
      equity in (gain) income from non-consolidated entities, net of distributions
    		          -1,100,000                   
      net periodic benefit income
    		          400,000  -200,000                 
      impairment of long-lived assets, definite and indefinite-lived intangible assets and goodwill
    		                   466,100,000          
      unrealized loss on investments hycroft
    		                             
      (gain) loss on sale of ncm investments
    		                             
      gain on disposition of assets
    		             0 -400,000               
      loss on derivative asset and derivative liability
    		                      19,600,000    28,400,000   
      proceeds from issuance of odeon term loan due 2023
    		               0 0 0 534,300,000           
      proceeds from issuance of first lien notes due 2025
    		                   0 0         
      proceeds from issuance of first lien notes due 2026
    		                   0          
      repurchase of second lien subordinated debt 2026
    		                             
      principal payments under odeon term loan due 2023
    		                             
      premium paid to extinguish odeon term loan due 2023
    		                             
      net proceeds from class a common stock issuance
    		               0 -100,000             
      net proceeds from class a common stock issuance to mudrick
    		               0 0             
      amc preferred equity units issuance costs payable at year end
    		                             
      mudrick transaction, see note 8-corporate borrowings and finance lease liabilities
    		                             
      dcip digital projectors transaction, see note 6-investments
    		                             
      loss on extinguishment of debt
    		            0 -38,600,000 135,000,000               
      unrealized loss on investments in ncm
    		                             
      loss on disposition of assets
    		                             
      gain on disposition of baltics
    		                0             
      loss on dispositions
    		                             
      amc preferred equity units issuance costs payable at period end
    		                             
      unrealized gain on investments in ncm
    		                             
      gain on derivative asset and derivative liability
    		                             
      other non-cash rent expense
    		                  -7,500,000           
      proceeds from issuance of term loan due 2026
    		                       0 0     
      payment of principal senior secured notes due 2023
    		                       0 0     
      payment of principal senior subordinated notes due 2022
    		                       0 0     
      call premiums paid for senior secured notes due 2023 and senior subordinated notes due 2022
    		                       0 0     
      principal payment of term loans due 2022 and 2023
    		                       0 0     
      borrowings (repayments) under revolving credit facilities
    		               0 0 0 -335,000,000 -400,000 -600,000 -2,300,000 325,100,000 -10,300,000    -6,599,987.9  
      (payments) proceeds related to sale of noncontrolling interest
    		                             
      principal payments under promissory note
    		                             
      income taxes received
    		               -1,400,000              
      convertible notes due 2026 conversion, see note 8-corporate borrowings and finance lease obligations
    		                             
      mudrick transaction, see note 8-corporate borrowings and finance lease obligations
    		                             
      gain on dispositions
    		                   -14,100,000 -900,000 -1,400,000 -1,000,000 -1,400,000 0 -3,100,000 -12,900,000 2,899,996.8 -100,000 
      proceeds from class a common stock issuance
    		                  581,600,000 261,900,000          
      net earnings
    		                         49,400,000 -130,200,000   
      adjustments to reconcile net earnings to net cash from operating activities:
    		                             
      gain on disposition of ncm
    		                             
      ncm held-for-sale impairment loss
    		                           -15,999,984 0 
      other non-cash rent
    		                   -3,200,000 -200,000 -3,800,000 2,300,000       
      proceeds from sale leaseback transactions
    		                           -50,099,949.9 0 
      proceeds from disposition of ncm
    		                           -162,499,837.5  
      proceeds from screenvision merger
    		                           -45,799,954.2  
      proceeds from issuance of senior unsecured convertible notes due 2024
    		                           -599,999,400  
      scheduled principal payments under term loans
    		                   -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000     
      proceeds from sale of noncontrolling interest
    		                   -500,000          
      retirement of class b common stock
    		                           422,899,576.4  
      purchase of treasury stock
    		                           21,799,978.2 -2,000,000 
      income taxes (received) paid
    		                             
      (gain) loss on derivative asset and derivative liability
    		                    95,800,000         
      loss on repayment of indebtedness
    		                        0     
      impairment of long-lived assets, indefinite-lived intangible assets and goodwill
    		                     0 1,851,900,000       
      amortization of net discount on corporate borrowings
    		                     3,500,000 3,100,000       
      amortization of deferred charges to interest expense
    		                     4,300,000 4,100,000 4,000,000 4,000,000 3,400,000 4,400,000 -11,499,984 4,000,000 
      loss on ncm charged to merger, acquisition and transaction costs
    		                             
      amortization of net discount (premium) on corporate borrowings
    		                       3,200,000 3,100,000 2,800,000 2,200,000   
      gain on sale of open road
    		                             
      repayment of nordic interest rate swaps
    		                             
      non-cash rent - purchase accounting
    		                       6,200,000 6,100,000 5,800,000 7,600,000   
      change in assets and liabilities, excluding acquisitions:
    		                             
      acquisition of nordic cinemas group, net of cash and restricted cash acquired
    		                             
      proceeds from disposition of open road
    		                             
      proceeds from issuance of senior subordinated sterling notes due 2024
    		                             
      proceeds from issuance of senior subordinated notes due 2027
    		                             
      payment of nordic sek term loan
    		                             
      payment of nordic eur term loan
    		                             
      net proceeds from equity offering
    		                             
      principal payment of bridge loan due 2017
    		                             
      principal payments under capital and financing lease obligations
    		                       -2,400,000 -2,400,000 -2,300,000 -3,800,000 53,499,929 -17,600,000 
      accrued treasury stock payable at period end
    		                             
      cash used to pay for debt financing costs
    		                        -500,000     
      loss on disposition of ncm
    		                             
      principal payments under term loan
    		                          -3,400,000 10,299,986.2 -3,400,000 
      amortization of net premium on corporate borrowings
    		                           2,100,000.2 -400,000 
      theatre and other closure expense
    		                           -3,099,997.3 900,000 
      (gain) loss on disposition of ncm
    		                           29,999,969.4  
      acquisition of odeon and uci cinemas limited, net of cash and restricted cash acquired
    		                             
      acquisition of carmike cinemas, inc., net of cash and restricted cash acquired
    		                             
      acquisition of starplex cinemas
    		                             
      proceeds from theatre partnership
    		                             
      proceeds from issuance of term loan due 2023
    		                             
      proceeds from issuance of senior subordinated notes due 2026
    		                             
      proceeds from issuance of bridge loan due 2017
    		                             
      payment of odeon senior subordinated gbp notes due 2018
    		                             
      payment of odeon senior subordinated eur notes due 2018
    		                             
      payment of stock issuance offering costs
    		                             
      loss on derivative liability
    		                             
      proceeds from disposition of ncm, inc. shares
    		                             
      borrowings (repayments) under revolving credit facility
    		                             
      operating activities:
    		                             
      adjustments to reconcile net income to net cash
    		                             
      provided by operating activities:
    		                             
      amortization of deferred warranty reimbursement costs
    		                             
      amortization of deferred financing costs
    		                             
      (gain) loss on sale of assets
    		                             
      changes in operating assets and liabilities:
    		                             
      accounts receivable
    		                             
      other current and noncurrent assets
    		                             
      accounts payable and accrued liabilities
    		                             
      warranty reimbursement liability
    		                             
      payment of prior period warranty reimbursement liability
    		                             
      other noncurrent liabilities
    		                             
      investing activities:
    		                             
      purchase of property and equipment
    		                             
      payment of prior period property and equipment
    		                             
      sale of property and equipment
    		                             
      restricted cash
    		                             
      financing activities:
    		                             
      paydown of long-term debt
    		                             
      capital contributions from members
    		                             
      distributions to members
    		                             
      deferred financing costs
    		                             
      net increase in cash and cash equivalents
    		                             
      cash and cash equivalents, beginning of year
    		                             
      cash and cash equivalents, end of year
    		                             
      supplemental schedule of non-cash investing and financing activities:
    		                             
      additions to property and equipment included in accounts payable
    		                             
      and accrued liabilities
    		                             
      warranty reimbursement payable in accounts payable and accrued liabilities
    		                             
      deferred warranty asset and warranty reimbursement obligation
    		                             
      loss on refinancing
    		                             
      paid-in-kind interest
    		                             
      increase in long-term debt
    		                             
      additions to property and equipment included in accounts payable and accrued liabilities
    		                             
      stock-based compensation
    		                             
      equity in earnings and losses from non-consolidated entities, net of distributions
    		                             
      net periodic benefit credit
    		                             
      acquisition of starplex cinemas, net of cash acquired
    		                             
      proceeds from issuance of senior subordinated notes due 2025
    		                             
      payments under revolver credit facility
    		                             
      repurchase of senior subordinated notes due 2020
    		                             
      principal amount of coupon payment under senior subordinated notes due 2020
    		                             
      effect of exchange rate changes on cash and equivalents
    		                             
      net decrease in cash and equivalents
    		                             
      cash and equivalents at beginning of period
    		                             
      cash and equivalents at end of period
    		                             
      income taxes paid (refunded)
    		                             
      schedule of non-cash operating and investing activities:
    		                             
      loss on redemption of 9.75% senior subordinated notes due 2020
    		                             
      other income
    		                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.